The global demand for Continuous Glucose Monitoring Meter Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028.
Continuous glucose monitoring (CGM) meter enables automatic tracking of blood glucose levels throughout the day and night using a sensor that sends readings to an insulin pump. The monitoring process includes a transmitter, receiver, and insulin pump. CGM provides a complete picture of blood glucose levels by giving early warnings of lows and highs that even HbA1C and finger stick testing cannot identify. It offers exceptional comfort and performance. Continuous glucose monitoring meter is especially beneficial for people with widely variable blood sugar levels, frequent low glucose levels, and those who want to reduce their A1C targets without increasing extreme events.
Market Dynamics
The prime factors driving the global continuous glucose monitoring meter market are the rising burden of diabetic patients and the increasing demand for minimally invasive monitoring devices. As per Diabetes Research and Clinical Practice, the global diabetes prevalence in 2019 was estimated to be 463 million people, rising to 10.2% by 2030 and 10.9% by 2045. Growing approvals by FDA for new CGM monitoring device is projected to boost competition as well as revenue. Players are focused on bringing monitoring devices for type 2 diabetes and devices with enhanced accuracy and assistance. However, the presence of other alternatives and the need to finger-stick glucose test twice a day to check the accuracy of CGM against a standard blood glucose meter is likely to impede growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of continuous glucose monitoring meter.
Market Segmentation
This section of the continuous glucose monitoring meter market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Component
- Transmitters
- Receivers
- Sensors
By End-Use
- Hospitals
- Homecare Settings
- Others
By Application
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Continuous Glucose Monitoring Meter market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Continuous Glucose Monitoring Meter Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the continuous glucose monitoring meter market include Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.